(Q45722014)

English

Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery

scientific article published on 19 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery (English)

1 reference

Europe PubMed Central

15 December 2017

1 reference

based on heuristic

inferred from title

tumour xenograft

1 reference

based on heuristic

inferred from title

Vasilis Ntziachristos

6

object named as

Vasilis Ntziachristos

1 reference

Europe PubMed Central

15 December 2017

author name string

Marta Kijanka

1

1 reference

Europe PubMed Central

15 December 2017

Frank-Jan Warnders

2

1 reference

Europe PubMed Central

15 December 2017

Mohamed El Khattabi

3

1 reference

Europe PubMed Central

15 December 2017

Marjolijn Lub-de Hooge

4

1 reference

Europe PubMed Central

15 December 2017

Gooitzen M van Dam

5

1 reference

Europe PubMed Central

15 December 2017

Liesbeth de Vries

7

1 reference

Europe PubMed Central

15 December 2017

Sabrina Oliveira

8

1 reference

Europe PubMed Central

15 December 2017

Paul M P van Bergen En Henegouwen

9

1 reference

Europe PubMed Central

15 December 2017

publication date

19 June 2013

1 reference

Europe PubMed Central

15 December 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

15 December 2017

40

1 reference

Europe PubMed Central

15 December 2017

11

1 reference

Europe PubMed Central

15 December 2017

1718-1729

1 reference

Europe PubMed Central

15 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-013-2471-2

0 references

Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Current technologies for HER2 testing in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Translation of near-infrared fluorescence imaging technologies: emerging clinical applications

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Molecular imaging in living subjects: seeing fundamental biological processes in a new light

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Src family kinases and HER2 interactions in human breast cancer cell growth and survival

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

A modeling analysis of the effects of molecular size and binding affinity on tumor targeting

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Evaluation of ((4-hydroxyphenyl)ethyl)maleimide for site-specific radiobromination of anti-HER2 affibody.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenografts.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Prognostic factors in metastatic breast cancer: successes and challenges toward individualized therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23778558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23778558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions

1 reference

https://pubmed.ncbi.nlm.nih.gov/23778558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics and pharmacodynamics of monoclonal antibodies--mechanistic modeling applied to drug development.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23778558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The HER2 testing conundrum

1 reference

https://pubmed.ncbi.nlm.nih.gov/23778558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

1 reference

https://pubmed.ncbi.nlm.nih.gov/23778558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-013-2471-2

1 reference

Europe PubMed Central

15 December 2017

Dimensions Publication ID

0 references

release_zmqnm355s5cf3lpm2uw3gz5yqy

1 reference

https://api.fatcat.wiki/v0/release/zmqnm355s5cf3lpm2uw3gz5yqy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45722014&oldid=2077820557"